Marin Nishimura1, Gregory M Marcus2, Paul D Varosy3, Haikun Bao4, Yongfei Wang4, Jeptha P Curtis4, Jonathan C Hsu5. 1. Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Diego, San Diego, CA, USA. 2. Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. 3. Division of Cardiology, Department of Electrophysiology, VA Eastern Colorado Health Care System, University of Colorado, Denver, CO, USA. 4. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. 5. Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Diego, San Diego, CA, USA. Jonathan.Hsu@ucsd.edu.
Abstract
BACKGROUND: Cardiac resynchronization therapy with defibrillator (CRT-D) implantation involves left ventricular (LV) lead placement for biventricular pacing and is more complex than implantable cardioverter-defibrillator (ICD)-only implantation. Differences in the prescription of CRT-D versus ICD may result from clinician biases based on patient body habitus, and body habitus may be associated with LV lead implantation failure. OBJECTIVE: We sought to evaluate whether patient body mass index (BMI) was associated with planned use and implantation failure of CRT-D therapy. METHODS: We studied all patients enrolled in the National Cardiovascular Data Registry ICD Registry who met standard CRT-D criteria and received either an ICD or CRT-D between 2010 and 2012. BMI was categorized based on World Health Organization classification. Using hierarchical logistic regression, two multivariate models adjusted for patient demographic and clinical characteristics were fit based on the following outcome variables: (1) planned implantation with CRT-D versus ICD and (2) failed versus successful LV lead placement. RESULTS: Of 337,547 patients, 41,872 met inclusion criteria for the first analysis and 35,186 met criteria for the second analysis. After multivariable adjustment, patients with extreme (BMI > 40 kg/m2) obesity were less likely to receive guideline-concordant CRT-D compared with patients with normal weight (adjusted odds ratio (AOR), 0.86; 95% confidence interval (CI), 0.75-0.99; p = 0.04). Extreme (BMI > 40 kg/m2) obesity was associated with higher odds of failed LV lead placement (AOR, 1.35; 95% CI, 1.07-1.72, p = 0.01). CONCLUSIONS: Compared with normal weight patients, extremely obese (BMI > 40 kg/m2) CRT-D eligible patients were less likely to be prescribed CRT-D and were at higher odds for failed LV lead placement.
BACKGROUND: Cardiac resynchronization therapy with defibrillator (CRT-D) implantation involves left ventricular (LV) lead placement for biventricular pacing and is more complex than implantable cardioverter-defibrillator (ICD)-only implantation. Differences in the prescription of CRT-D versus ICD may result from clinician biases based on patientbody habitus, and body habitus may be associated with LV lead implantation failure. OBJECTIVE: We sought to evaluate whether patient body mass index (BMI) was associated with planned use and implantation failure of CRT-D therapy. METHODS: We studied all patients enrolled in the National Cardiovascular Data Registry ICD Registry who met standard CRT-D criteria and received either an ICD or CRT-D between 2010 and 2012. BMI was categorized based on World Health Organization classification. Using hierarchical logistic regression, two multivariate models adjusted for patient demographic and clinical characteristics were fit based on the following outcome variables: (1) planned implantation with CRT-D versus ICD and (2) failed versus successful LV lead placement. RESULTS: Of 337,547 patients, 41,872 met inclusion criteria for the first analysis and 35,186 met criteria for the second analysis. After multivariable adjustment, patients with extreme (BMI > 40 kg/m2) obesity were less likely to receive guideline-concordant CRT-D compared with patients with normal weight (adjusted odds ratio (AOR), 0.86; 95% confidence interval (CI), 0.75-0.99; p = 0.04). Extreme (BMI > 40 kg/m2) obesity was associated with higher odds of failed LV lead placement (AOR, 1.35; 95% CI, 1.07-1.72, p = 0.01). CONCLUSIONS: Compared with normal weight patients, extremely obese (BMI > 40 kg/m2) CRT-D eligible patients were less likely to be prescribed CRT-D and were at higher odds for failed LV lead placement.
Entities:
Keywords:
Biventricular pacing; Body mass index; Cardiac resynchronization therapy; Implantable cardioverter-defibrillator
Authors: Emile G Daoud; Steven J Kalbfleisch; John D Hummel; Raul Weiss; Ralph S Augustini; Steven B Duff; Georgia Polsinelli; John Castor; Tejas Meta Journal: J Cardiovasc Electrophysiol Date: 2002-10
Authors: Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245
Authors: Stephen C Hammill; Mark S Kremers; Lynne Warner Stevenson; Alan H Kadish; Paul A Heidenreich; Bruce D Lindsay; Michael J Mirro; Martha J Radford; Yongfei Wang; Jeptha P Curtis; Christine M Lang; Joel C Harder; Ralph G Brindis Journal: Heart Rhythm Date: 2008-07-22 Impact factor: 6.343
Authors: Ian J Neeland; Sandeep R Das; DaJuanicia N Simon; Deborah B Diercks; Karen P Alexander; Tracy Y Wang; James A de Lemos Journal: Eur Heart J Qual Care Clin Outcomes Date: 2017-07-01
Authors: Philipp Attanasio; Philipp Lacour; Andrea Ernert; Burkert Pieske; Wilhelm Haverkamp; Florian Blaschke; Francesco Dalle Vedove; Martin Huemer Journal: Clin Cardiol Date: 2017-03-23 Impact factor: 2.882
Authors: Vidal Essebag; Jacqueline Joza; David H Birnie; John L Sapp; Laurence D Sterns; Francois Philippon; Raymond Yee; Eugene Crystal; Teresa Kus; Claus Rinne; Jeffrey S Healey; Magdi Sami; Bernard Thibault; Derek V Exner; Benoit Coutu; Chris S Simpson; Zaev Wulffhart; Elizabeth Yetisir; George Wells; Anthony S L Tang Journal: Circ Arrhythm Electrophysiol Date: 2014-11-23
Authors: Eric W Holroyd; Alex Sirker; Chun Shing Kwok; Evangelos Kontopantelis; Peter F Ludman; Mark A De Belder; Robert Butler; James Cotton; Azfar Zaman; Mamas A Mamas Journal: JACC Cardiovasc Interv Date: 2017-07-10 Impact factor: 11.195